A coalition of anti-cannabis groups has filed suit in federal court seeking to block what it characterizes as the coverage of non-FDA-approved hemp products under Medicare-linked programs.
The lawsuit, led by Smart Approaches to Marijuana and other groups, challenges a Medicare pilot program that lets providers give certain items—including CBD—to patients under flexible care rules.
Plaintiffs argue the Centers for Medicare & Medicaid Services is effectively opening a pathway for cannabinoid products that have not been approved by the U.S. Food and Drug Administration (USDA).
